Özkan, B.; Altuntaş, E.; Ünlü, Ü.; Doğan, H.H.; Özsoy, Y.; Çakır Koç, R.
Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus. Pharmaceutics 2023, 15, 2055.
https://doi.org/10.3390/pharmaceutics15082055
AMA Style
Özkan B, Altuntaş E, Ünlü Ü, Doğan HH, Özsoy Y, Çakır Koç R.
Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus. Pharmaceutics. 2023; 15(8):2055.
https://doi.org/10.3390/pharmaceutics15082055
Chicago/Turabian Style
Özkan, Burcu, Ebru Altuntaş, Ümmühan Ünlü, Hasan Hüseyin Doğan, Yıldız Özsoy, and Rabia Çakır Koç.
2023. "Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus" Pharmaceutics 15, no. 8: 2055.
https://doi.org/10.3390/pharmaceutics15082055
APA Style
Özkan, B., Altuntaş, E., Ünlü, Ü., Doğan, H. H., Özsoy, Y., & Çakır Koç, R.
(2023). Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus. Pharmaceutics, 15(8), 2055.
https://doi.org/10.3390/pharmaceutics15082055